Lancet Formally Retracts Jikei Heart Study of Novartis AG's Diovan

The Lancet has formally retracted the Jikei Heart Study paper, originally published in 2007. The retraction had been widely anticipated for more than a month, after a series of news reports in Japan made it clear that the long-simmering controversy over scientific misconduct involving the Novartis NVS +0.4% blood pressure lowering drug valsartan (Diovan) had come to a full boil. As reported previously, the current scandal first began to unfold in late 2011 when a Japanese blogger pointed to a number of apparent errors in publications authored by Hiroaki Matsubara.

Help employers find you! Check out all the jobs and post your resume.